Long run, they're all dead

Zyprexa is not an exception. The organization of American corporations, as applied to pharmaceuticals, guarantees that executives and sales people will injure their customers to make a quick buck. These people have to be paid well to overcome any moral qualms they might have, but in any case, they will move on with their bonuses and stock grants long before any process to assign legal liability can retrieve them.

This is the reason we see so many bad drugs in the marketplace.

Long-term clawback provisions in statute, not left to mere case law, could help align incentives with a longer term set of interests and efficiencies that take into account something beyond the current quarter.

They don't care

Could it be any more obvious?

Separately, the Government Accountability Office will release a report on Tuesday showing that the F.D.A. would need to spend at least $56 million more next year to begin full inspections of foreign plants. It would need to spend at least $15 million annually to inspect China’s drug plants every two years, which is the domestic standard.

Bush administration officials have acknowledged problems associated with poor inspection of overseas plants and have plans to improve the situation. But President Bush’s budget does not provide the F.D.A. with funds to hire more inspectors.

How many minutes in Iraq?

At its present inspection pace, the F.D.A. would need at least 27 years to inspect every foreign medical device plant that exports to the United States, 13 years to check every foreign drug plant and 1,900 years to examine every foreign food plant.